Jazz Pharmaceuticals, plc (JAZZ) Completes EUSA Pharma Acquisition
6/12/2012 11:06:44 AM
More...
|
Jazz Pharmaceuticals, Inc. (JAZZ) Buying EUSA Pharma for Up to $700 Million
4/27/2012 7:34:48 AM
More...
|
Alize Pharma Licenses its ASPAREC(R) Therapy for Treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma
2/2/2012 10:59:33 AM
More...
|
EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC(R) for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma
2/2/2012 9:56:44 AM
More...
|
AIBioTech Assists EUSA Pharma in Obtaining FDA Approval for a Critical Drug Product
11/22/2011 7:53:20 AM
More...
|
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia
11/18/2011 7:15:08 AM
More...
|
EUSA Pharma Submits ERWINASE(R) Biologics License Application (BLA) for Treatment of Acute Lymphoblastic Leukemia
11/9/2010 11:24:29 AM
More...
|
EUSA Pharma Announces the Appointment of Stephen A. Stamp to Its Board of Directors
9/1/2010 11:03:54 AM
More...
|
EUSA Pharma Grants Japanese Rights To Erwinase(R) Oncology Therapy To Ohara Pharmaceutical
7/6/2010 2:32:48 PM
More...
|
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
3/8/2010 7:17:33 AM
More...
|
|